Protalix BioTherapeutics Inc.

ASE:PLX   2:24:39 PM EDT
1.91
+0.10 (+5.52%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)152.28M
Current PE24.27
Forward PE 14.69
2yr Forward PE 3.47
See more stats
Estimates Current Quarter
Revenue$17.89 Million
Adjusted EPS$0.06
See more estimates
10-Day MA$1.72
50-Day MA$1.55
200-Day MA$1.98
See more pivots

Protalix BioTherapeutics Inc. Stock, ASE:PLX

2 University Plaza, Suite 100, Hackensack, New Jersey 07601
United States of America
Phone: +1.201.696.9345
Number of Employees: 213

Description

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.